Article
Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 1 Feb 2010
Damm Frederik, Heuser Michael, Morgan Michael, Yun Haiyang, Grosshennig Anika, Göhring Gudrun, Schlegelberger Brigitte, Döhner Konstanze, Ottmann Oliver, Lübbert Michael, Heit Wolfgang, Kanz Lothar, Schlimok Günter, Raghavachar Aruna, Fiedler Walter, Kirchner Hartmut, Döhner Hartmut, Heil Gerhard, Ganser Arnold, Krauter Jürgen
Abstract excerpt
PURPOSE: We assessed the prognostic impact of a known single nucleotide polymorphism (SNP) located in the mutational hotspot of WT1 in patients with cytogenetically normal acute myeloid leukemia (CN-AML) in the context of other prognostic markers. PATIENTS AND METHODS: WT1 exons 7 and 9 from 249 CN-AML patients from multicenter treatment trials AML-SHG Hannover 0199 (Clinical Trials Identifier NCT00209833) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
